Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF for pediatric liver failure
ChiCTR1900021753Phase 4Not yet recruiting
- Sponsor
- Children's Hospital of Chongqing Medical University
- Start
- Nov 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of granulocyte colony-stimulating factor in hepatic failure (2 arms), sponsored by Children's Hospital of Chongqing Medical University. Primary endpoints: 1-month survival rate and 3-month survival. Planned start Nov 2019; status: not yet recruiting.
02
Drugs
granulocyte colony-stimulating factor
03
Conditions
hepatic failure
Beyond the preview
Go deeper on ChiCTR1900021753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021753.